Moneycontrol PRO
sun pharmaceutical industries
Jump to
2335 Results Found
  • Buy Sun Pharmaceutical Industries; target of Rs 965: ICICI Direct Nov 05, 2021 11:02 AM IST

    Buy Sun Pharmaceutical Industries; target of Rs 965: ICICI Direct

    ICICI Direct is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 965 in its research report dated November 03, 2021.

  • Sun Pharma Standalone September 2021 Net Sales at Rs 4,143.15 crore, up 25.84% Y-o-Y Nov 03, 2021 10:22 AM IST

    Sun Pharma Standalone September 2021 Net Sales at Rs 4,143.15 crore, up 25.84% Y-o-Y

  • Sun Pharma Consolidated September 2021 Net Sales at Rs 9,625.93 crore, up 12.54% Y-o-Y Nov 03, 2021 09:44 AM IST

    Sun Pharma Consolidated September 2021 Net Sales at Rs 9,625.93 crore, up 12.54% Y-o-Y

  • Sun Pharma: Buy, sell or hold? What should investors do after Q2 results? Nov 03, 2021 09:27 AM IST

    Sun Pharma: Buy, sell or hold? What should investors do after Q2 results?

    Sun Pharma’s consolidated revenue came in higher at Rs 9,626 crore for the quarter, compared to Rs 8,553 crore in September 2020 quarter, registering a 12.5 percent growth.

  • Sun Pharma Q2 Results | Profit rises 13% to Rs 2,047 crore, revenue grows 12.5% Nov 02, 2021 01:36 PM IST

    Sun Pharma Q2 Results | Profit rises 13% to Rs 2,047 crore, revenue grows 12.5%

    Sun Pharma Q2 Results | The sequential growth in profit and revenue was 41.8 percent and (-1) percent respectively.

  • Sun Pharma launches acne treatment cream Winlevi in US market Nov 01, 2021 12:25 PM IST

    Sun Pharma launches acne treatment cream Winlevi in US market

    A first-in-class topical androgen receptor inhibitor, Winlevi was approved by the US Food and Drug Administration (FDA) in August 2020.

  • Sun Pharmaceutical Industries Q2 PAT seen up 15.6% YoY to Rs 2,094.8 cr: Prabhudas Lilladher Oct 06, 2021 06:00 PM IST

    Sun Pharmaceutical Industries Q2 PAT seen up 15.6% YoY to Rs 2,094.8 cr: Prabhudas Lilladher

    Net Sales are expected to increase by 13.3 percent Y-o-Y (down 0.9 percent Q-o-Q) to Rs 9,584.3 crore, according to Prabhudas Lilladher.

  • Hot Stocks: 'Can bet on Sun Pharma, BHEL and Canara Bank for double-digit returns in 2-3 weeks' Oct 01, 2021 07:24 AM IST

    Hot Stocks: 'Can bet on Sun Pharma, BHEL and Canara Bank for double-digit returns in 2-3 weeks'

    The key support levels to watch for in the short term are 17,531 (20-Day SMA) and 17,254 (3-Week Low), said Vidnyan Sawant of GEPL Capital,

  • Hot Stocks | Here's why you should buy Sun Pharma & Dixon Tech, but sell Britannia futures Sep 30, 2021 07:12 AM IST

    Hot Stocks | Here's why you should buy Sun Pharma & Dixon Tech, but sell Britannia futures

    As Nifty is still trading within the rising channel pattern, the bullish trend is most likely to continue, going ahead, says Rohan Patil of Bonanza Portfolio.

  • Sun Pharma Consolidated June 2021 Net Sales at Rs 9,718.74 crore, up 28.13% Y-o-Y Aug 03, 2021 09:22 AM IST

    Sun Pharma Consolidated June 2021 Net Sales at Rs 9,718.74 crore, up 28.13% Y-o-Y

  • Sun Pharma Standalone June 2021 Net Sales at Rs 3,325.95 crore, up 12.25% Y-o-Y Aug 03, 2021 08:44 AM IST

    Sun Pharma Standalone June 2021 Net Sales at Rs 3,325.95 crore, up 12.25% Y-o-Y

  • Buy Sun Pharmaceutical Industries: target of Rs 900: Sharekhan Aug 02, 2021 01:08 PM IST

    Buy Sun Pharmaceutical Industries: target of Rs 900: Sharekhan

    Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 900 in its research report dated July 30, 2021.

  • What should investors do with Sun Pharma post Q1 results: buy, sell or hold? Aug 02, 2021 10:08 AM IST

    What should investors do with Sun Pharma post Q1 results: buy, sell or hold?

    Sun Pharma Q1 results: Motilal Oswal is positive on the company due to - investments in the global Specialty portfolio improving overall profitability, robust pipeline of NDAs/ANDAs, and revival in the Branded Generics segment

  • Sun Pharma posts Rs 1,444.17-crore net profit in June quarter Jul 30, 2021 03:41 PM IST

    Sun Pharma posts Rs 1,444.17-crore net profit in June quarter

    The company had posted a net loss of Rs 1,655.60 crore for the corresponding period of the previous fiscal, Sun Pharma said in a regulatory filing.

  • Sun Pharma share price locked in 10% upper circuit on turning profitable in Q1FY22 Jul 30, 2021 03:18 PM IST

    Sun Pharma share price locked in 10% upper circuit on turning profitable in Q1FY22

    Sun Pharma has reported a net profit of Rs 1,444.1 crore in the quarter ended Q1FY22 against a loss of Rs 1,655.6 crore in the year-ago period

  • Sun Pharmaceutical Industries Q1 PAT seen up 17.5% YoY to Rs 1,346.7 cr: KRChoksey Jul 13, 2021 11:37 AM IST

    Sun Pharmaceutical Industries Q1 PAT seen up 17.5% YoY to Rs 1,346.7 cr: KRChoksey

    Net Sales are expected to increase by 12.7 percent Y-o-Y (up 0.3 percent Q-o-Q) to Rs 8,547.7 crore, according to KRChoksey.

  • Buy Sun Pharmaceutical Industries; target of Rs 783: Geojit Jun 04, 2021 02:27 PM IST

    Buy Sun Pharmaceutical Industries; target of Rs 783: Geojit

    Geojit is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 783 in its research report dated June 02, 2021.

  • Hold Sun Pharmaceutical Industries; target of Rs 700: ICICI Direct Jun 01, 2021 10:34 AM IST

    Hold Sun Pharmaceutical Industries; target of Rs 700: ICICI Direct

    ICICI Direct recommended hold rating on Sun Pharmaceutical Industries with a target price of Rs 700 in its research report dated May 28, 2021.

  • Buy Sun Pharmaceutical Industries: target of Rs 810: Sharekhan May 31, 2021 01:38 PM IST

    Buy Sun Pharmaceutical Industries: target of Rs 810: Sharekhan

    Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 810 in its research report dated May 27, 2021.

  • Sun Pharma Consolidated March 2021 Net Sales at Rs 8,522.98 crore, up 4.13% Y-o-Y May 28, 2021 02:25 PM IST

    Sun Pharma Consolidated March 2021 Net Sales at Rs 8,522.98 crore, up 4.13% Y-o-Y

  • Sun Pharma Standalone March 2021 Net Sales at Rs 3,159.64 crore, up 11.41% Y-o-Y May 28, 2021 02:00 PM IST

    Sun Pharma Standalone March 2021 Net Sales at Rs 3,159.64 crore, up 11.41% Y-o-Y

  • What should investors do with Sun Pharma post Q4 earnings: buy, sell or hold? May 28, 2021 09:40 AM IST

    What should investors do with Sun Pharma post Q4 earnings: buy, sell or hold?

    Here is what brokerages have to say about the stock and the company after the March quarter earnings announcement:

  • Sun Pharma Q4 net profit zooms over two-fold to Rs 894.15 crore May 27, 2021 07:50 PM IST

    Sun Pharma Q4 net profit zooms over two-fold to Rs 894.15 crore

    For the full fiscal 2020-21, the company posted a net profit of Rs 2,903.82 crore as against Rs 3,764.93 crore in the previous financial year.

  • Sun Pharma to announce Q4 results today; here what brokerages expect May 27, 2021 08:43 AM IST

    Sun Pharma to announce Q4 results today; here what brokerages expect

    The pharma major is likely to report a more than 100 percent year-on-year growth in profit, backed by healthy operating performance, and low base in the year-ago quarter.

  • Buy Sun Pharmaceutical Industries: target of Rs 700: Sharekhan Apr 05, 2021 02:19 PM IST

    Buy Sun Pharmaceutical Industries: target of Rs 700: Sharekhan

    Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 700 in its research report dated April 01, 2021.

Sections
ISO 27001 - BSI Assurance Mark